Justin Park

Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)

S. Nicolaou, Hyon K. Choi, P. Traber, 2023, Rheumatology and Therapy.